Updated Date:
27 Mar 2026
Product Detail:
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 405mg powder for injection vial with diluent vial
Shortage Status:
Current
AUST R:
143636
Availability:
Limited Availability
Active Ingredient:
olanzapine pamoate monohydrate
Reason:
Transport / Logistic issues / Storage capacity issues
Dosage Form:
Injection,powderfor
Supply Impact Dates
From 19 Dec 2025
To 30 Jun 2026
Management Action:
The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under Section 19A. The approval holder, Aborns Pharmaceuticals Pty Ltd, can be contacted for details on supply on 1300 117 772.